19-45385569-G-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_006663.4(PPP1R13L):c.2241C>G(p.Tyr747Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
PPP1R13L
NM_006663.4 stop_gained
NM_006663.4 stop_gained
Scores
2
4
1
Clinical Significance
Conservation
PhyloP100: 0.789
Genes affected
PPP1R13L (HGNC:18838): (protein phosphatase 1 regulatory subunit 13 like) IASPP is one of the most evolutionarily conserved inhibitors of p53 (TP53; MIM 191170), whereas ASPP1 (MIM 606455) and ASPP2 (MIM 602143) are activators of p53.[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-45385569-G-C is Pathogenic according to our data. Variant chr19-45385569-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 427813.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP1R13L | NM_006663.4 | c.2241C>G | p.Tyr747Ter | stop_gained | 11/13 | ENST00000360957.10 | NP_006654.2 | |
PPP1R13L | NM_001142502.2 | c.2241C>G | p.Tyr747Ter | stop_gained | 11/13 | NP_001135974.1 | ||
PPP1R13L | XM_017026177.2 | c.2241C>G | p.Tyr747Ter | stop_gained | 12/14 | XP_016881666.1 | ||
PPP1R13L | XM_017026178.2 | c.2241C>G | p.Tyr747Ter | stop_gained | 12/14 | XP_016881667.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP1R13L | ENST00000360957.10 | c.2241C>G | p.Tyr747Ter | stop_gained | 11/13 | 1 | NM_006663.4 | ENSP00000354218 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Cardio-cutaneous syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | research | Molecular Laboratory of the Institute of Human Genetics, Galilee Medical Center | - | - - |
Arrhythmogenic cardiomyopathy with variable ectodermal abnormalities Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 26, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at